Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.12
-0.13 (-1.86%)
Mar 6, 2026, 3:31 PM EST - Market open
ARCT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 82.03 | 152.31 | 166.8 | 206 | 12.36 | Upgrade
|
| Revenue Growth (YoY) | -46.14% | -8.69% | -19.03% | 1566.79% | 29.56% | Upgrade
|
| Cost of Revenue | 112.21 | 195.16 | 192.13 | 147.75 | 173.76 | Upgrade
|
| Gross Profit | -30.18 | -42.85 | -25.33 | 58.25 | -161.4 | Upgrade
|
| Selling, General & Admin | 46.08 | 52.82 | 52.87 | 46.07 | 41.45 | Upgrade
|
| Operating Expenses | 46.08 | 52.82 | 52.87 | 46.07 | 41.45 | Upgrade
|
| Operating Income | -76.26 | -95.67 | -78.21 | 12.18 | -202.85 | Upgrade
|
| Interest Expense | -0.01 | - | - | - | - | Upgrade
|
| Interest & Investment Income | 10.1 | 15.2 | 16.59 | - | - | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.52 | 0.52 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.38 | -0.47 | -0.23 | -0.6 | 0.58 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.42 | -1.92 | Upgrade
|
| EBT Excluding Unusual Items | -65.78 | -80.95 | -61.84 | 10.64 | -203.67 | Upgrade
|
| Other Unusual Items | - | - | 33.95 | - | - | Upgrade
|
| Pretax Income | -65.78 | -80.95 | -27.89 | 10.64 | -203.67 | Upgrade
|
| Income Tax Expense | - | -0 | 1.84 | 1.3 | - | Upgrade
|
| Net Income | -65.78 | -80.94 | -29.73 | 9.35 | -203.67 | Upgrade
|
| Net Income to Common | -65.78 | -80.94 | -29.73 | 9.35 | -203.67 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 27 | 27 | 26 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 27 | 27 | 26 | Upgrade
|
| Shares Change (YoY) | 1.43% | 1.40% | -1.72% | 2.95% | 29.61% | Upgrade
|
| EPS (Basic) | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | Upgrade
|
| EPS (Diluted) | -2.40 | -3.00 | -1.12 | 0.35 | -7.74 | Upgrade
|
| Free Cash Flow | -74.5 | -60.4 | -21 | 24.27 | -138.45 | Upgrade
|
| Free Cash Flow Per Share | -2.72 | -2.24 | -0.79 | 0.90 | -5.26 | Upgrade
|
| Gross Margin | -36.79% | -28.13% | -15.19% | 28.28% | - | Upgrade
|
| Operating Margin | -92.97% | -62.81% | -46.89% | 5.91% | -1641.33% | Upgrade
|
| Profit Margin | -80.19% | -53.14% | -17.82% | 4.54% | -1647.98% | Upgrade
|
| Free Cash Flow Margin | -90.82% | -39.65% | -12.59% | 11.78% | -1120.23% | Upgrade
|
| EBITDA | -73.24 | -92.13 | -75.25 | 13.7 | -201.66 | Upgrade
|
| EBITDA Margin | -89.28% | -60.48% | -45.11% | 6.65% | - | Upgrade
|
| D&A For EBITDA | 3.03 | 3.54 | 2.96 | 1.53 | 1.19 | Upgrade
|
| EBIT | -76.26 | -95.67 | -78.21 | 12.18 | -202.85 | Upgrade
|
| EBIT Margin | -92.97% | -62.81% | -46.89% | 5.91% | - | Upgrade
|
| Effective Tax Rate | - | - | - | 12.17% | - | Upgrade
|
| Revenue as Reported | 82.03 | 152.31 | 166.8 | 206 | 12.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.